BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 19829142)

  • 1. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
    Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.
    Valente S; Lazzeri C; Chiostri M; Giglioli C; Sori A; Tigli S; Gensini GF
    Int J Cardiol; 2009 Feb; 132(1):84-9. PubMed ID: 18207587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate in the acute phase of ST-elevation myocardial infarction treated with mechanical revascularization: a single-center experience.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Am J Emerg Med; 2012 Jan; 30(1):92-6. PubMed ID: 21109381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention.
    Lazzeri C; Sori A; Chiostri M; Gensini GF; Valente S
    Eur J Anaesthesiol; 2009 Oct; 26(10):856-62. PubMed ID: 19367169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):419-23. PubMed ID: 20517158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.
    Barthélémy O; Beygui F; Vicaut E; Rouanet S; Van Belle E; Baulac C; Degrandsart A; Dallongeville J; Montalescot G;
    Am J Cardiol; 2009 Oct; 104(7):904-9. PubMed ID: 19766754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction.
    Ohlmann P; Jaquemin L; Morel O; El Behlgiti R; Faure A; Michotey MO; Beranger N; Roul G; Schneider F; Bareiss P; Monassier JP
    Am Heart J; 2006 Dec; 152(6):1161-7. PubMed ID: 17161070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
    Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
    Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.